Injectable GLP-1 · Brand name
Wegovy
Brand-name semaglutide from Novo Nordisk, an FDA-approved once-weekly GLP-1 injection for chronic weight management.
- Once-weekly injection
- Brand-name semaglutide
- FDA-approved for weight management
- Provider-reviewed before prescribed
$1,199/mo
Includes your provider consult and the medication, shipped to you.
Provider-reviewed · Cancel anytime
Every plan includes
- Licensed provider review of your intake
- Brand-name Wegovy shipped to you when prescribed
- Unlimited messaging with your care team and provider
- Free shipping on every order
- Dose adjustments as your provider directs
What it is and how it works
Wegovy is the brand name for semaglutide, made by Novo Nordisk, and it is FDA-approved for chronic weight management. It is a GLP-1 receptor agonist that mimics a hormone your body releases after eating, which helps regulate appetite and how full you feel.
Wegovy is taken as a once-weekly injection, with the dose increased gradually over time. A Josie provider reviews your health history and intake before any prescription is issued.
Because Wegovy is a brand-name medication, it is typically the highest-cost GLP-1 option. Many women compare it to compounded semaglutide, which uses the same active molecule at a lower price.
Who it’s for
May be a fit if you
- Want the FDA-approved brand-name semaglutide specifically
- Are exploring provider-guided weight management
- Prefer a once-weekly injection pen
- Want licensed provider oversight and ongoing support
Not appropriate if you
- Have a personal or family history of medullary thyroid carcinoma or MEN 2
- Are pregnant, trying to conceive, or breastfeeding
- Have a history of pancreatitis or certain GI conditions (discuss with your provider)
- Are advised against GLP-1 care by your provider
Eligibility is always determined by a licensed provider after reviewing your intake.
How to take it
- 1Your provider confirms your starting dose and titration schedule.
- 2Inject once weekly with the Wegovy pen, on the same day each week.
- 3The dose is increased gradually over several weeks to help limit side effects.
- 4Store as instructed and message your care team for adjustments or questions.
Safety, risks & side effects
GLP-1 medications carry real risks. Review them with a licensed provider and read the full prescribing information before starting.
Boxed warning: In rodent studies, semaglutide caused thyroid C-cell tumors. It is not known whether Wegovy causes these tumors, including medullary thyroid carcinoma (MTC), in humans. Do not use if you or a family member has had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects
- Nausea
- Diarrhea or constipation
- Vomiting
- Abdominal pain
- Fatigue
Serious risks
- Pancreatitis (inflammation of the pancreas)
- Gallbladder problems
- Low blood sugar, especially with other diabetes medicines
- Kidney problems related to dehydration
- Serious allergic reactions
Do not use if you have
- Personal or family history of medullary thyroid carcinoma
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Known serious allergy to semaglutide
- Pregnancy or breastfeeding
Frequently asked questions
What is Wegovy?
Wegovy is the brand name for semaglutide, made by Novo Nordisk. It is a GLP-1 receptor agonist taken as a once-weekly injection and is FDA-approved for chronic weight management.
Is Wegovy FDA approved?
Yes. Unlike compounded semaglutide, Wegovy is an FDA-approved medication. You can review the FDA prescribing information for details on approved uses, dosing, and risks.
How is Wegovy different from compounded semaglutide?
Both use semaglutide as the active molecule. Wegovy is the FDA-approved brand-name product and is typically the highest-cost option. Compounded semaglutide is prepared by a licensed compounding pharmacy and is usually lower cost, but it is not FDA approved. A provider helps you decide which fits your goals and budget.
How is Wegovy different from Ozempic?
Both are brand-name semaglutide from Novo Nordisk. Wegovy is FDA-approved specifically for chronic weight management, while Ozempic is FDA-approved for type 2 diabetes. A licensed provider determines what is appropriate for you.
How much does it cost, and what is included?
The price shown is per month and includes your provider consult and the medication shipped to you. There is no separate membership fee. As a brand-name medication, Wegovy is typically the highest-cost GLP-1 option.
Is there a consultation fee?
There is no upfront fee to complete your intake. A $80 consultation fee applies only if a licensed provider approves your care plan and you then choose not to proceed with medication.
Do I need an in-person appointment?
No. Josie is telehealth. You complete an online intake and a licensed provider reviews your health history and goals. If they have questions, your care team follows up by message.
Which US states is Josie available in?
Josie is available in all 50 US states.
How do I start?
Complete the online intake. A licensed Josie provider reviews your history and, if appropriate, prescribes your plan, which is shipped from a licensed pharmacy.
Wegovy is a registered trademark of Novo Nordisk. Josie is not affiliated with, endorsed by, or sponsored by Novo Nordisk.
Medications are only issued when clinically appropriate after a provider evaluation. Prescription medications carry risks; read the full prescribing information before use.
What to Expect at Josie
- Complete your intake online, from anywhere
- Provider review by Josie's licensed clinicians, supervised by Dr. Ana Lisa Carr, MD
- Transparent program pricing
- Medication shipped from a licensed pharmacy or compounding pharmacy when prescribed